The overall findings from our study suggests that during progression from NAFLD to fibrosis nuclear expression of P2-HNF4α, which in our series is seen in over half of the cases, may be the first event to occur. This evidence concerns the gene HNF4A and metabolic dysfunction-associated steatotic liver disease.